A special double-episode of New Insight with Veeral Sheth, MD features a well-rounded conversation on all things ophthalmology with returning guest David Eichenbaum, MD, the director of research for Retina Vitreous Associates of Florida, as well as first-time guest Roger Goldberg, MD, a vitreoretinal surgeon at Bay Area Retina Associates. The trio of retina specialists discuss recent conference news, the anniversary of a landmark agent, and what’s to come in 2024 for the specialty. Episode Highlights: 0:00 Introduction 1:25 Entering 2024 7:34 The importance of treatment efficacy 12:09 Re-engaging GA treatment 15:05 Comparing aflibercept 8 mg and faricimab 23:00 Real-world data sets 26:30 What’s to come in 2024 27:45 Intravitreal gene therapies 31:00 Port delivery system 36:00 Wrapping-up  Every episode of New Insight is available on HCPLive.com and be sure to subscribe to our channel on Spotify and Apple Podcasts. Please direct any podcast-related inquiries to show producer Connor Iapoce at ciapoce@mjhlifesciences.com.